CHINA PHARMA HOLDINGS, INC. (CPHI) Operating margin 2016–2025
CHINA PHARMA HOLDINGS, INC. (CPHI) operating margin by fiscal year — reported operating income divided by reported revenue.
-78.2%FY2025 · since FY2016: -52.4% → -78.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -78.2% | +23.2 pp |
| FY2024 | -101.3% | -62.1 pp |
| FY2023 | -39.2% | +4.5 pp |
| FY2022 | -43.8% | -14.1 pp |
| FY2021 | -29.7% | -5.9 pp |
| FY2020 | -23.7% | +163.1 pp |
| FY2019 | -186.8% | -102.1 pp |
| FY2018 | -84.7% | +56.7 pp |
| FY2017 | -141.4% | -89.0 pp |
| FY2016 | -52.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice